This inventor holds 1 USPTO granted patent. Top assignee: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Xiaoda Niu
Introduction
Xiaoda Niu is a prominent inventor based in Sichuan, China. He has made significant strides in the field of pharmaceuticals, particularly in the treatment and prevention of tumors. His innovative work has led to the development of a unique pharmaceutical composition that holds promise for cancer therapy.
Latest Patents
Xiaoda Niu holds 1 patent for his invention titled "Pharmaceutical composition for tumor treatment or prevention, method, and use thereof." This patent describes a pharmaceutical composition that includes a 4'-thionucleoside phosphamide derivative or its pharmaceutically acceptable forms. The composition can be utilized in various crystalline forms or in combination with other drugs for effective disease treatment and prevention.
Career Highlights
Niu is currently associated with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., where he continues to contribute to advancements in biopharmaceuticals. His work focuses on developing innovative solutions that address critical health challenges, particularly in oncology.
Collaborations
Throughout his career, Xiaoda Niu has collaborated with notable colleagues, including Hong Zeng and Daibiao Xiao. These partnerships have fostered a collaborative environment that enhances research and development efforts in the biopharmaceutical sector.
Conclusion
Xiaoda Niu's contributions to pharmaceutical innovation are noteworthy, particularly in the realm of tumor treatment. His patent reflects a commitment to advancing medical science and improving patient outcomes.